Olli is a physician-scientist and a EMBO/MSCA postdoctoral fellow in the Garnett and Teichmann labs, focusing on deciphering genomic determinants of anti-cancer immunity and engineering improved cellular immunotherapies using single-cell genomics, organoid models and genetic engineering. 

Olli has a long-standing interest in combining computational analysis and high-throughput functional genomics at the intersection of immunology and cancer. Olli completed his medical degree and his PhD at the University of Helsinki in Finland, where he studied immune interactions and precision medicine in blood cancers with Prof. Satu Mustjoki. 

 

My publications

Loading publications...